Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A PHASE 2A, EXPLORATORY RANDOMIZED, SINGLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY OF WEIGHT LOSS INDUCED BY NKS-3 IN OBESE ADULTS

NCT07882654 is registered in ClinicalTrials.gov with EktaH as lead sponsor.

NCT NCT07882654
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07882654 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A PHASE 2A, EXPLORATORY RANDOMIZED, SINGLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY OF WEIGHT LOSS INDUCED BY NKS-3 IN OBESE ADULTS
Lead sponsor
EktaH
Phase
Phase 2
Overall status
Not yet recruiting
Start date
October 20, 2026
Completion date
February 7, 2027
Enrollment
31 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

obesity (bmi equal to or >30), obesity / overweight